|
VOLUME 30: NO. 7 JULY 2003
Editorials
Rheumatoid Arthritis and Tuberculosis:
Time To Take Notice

M. Gardam, K. Iverson .........1397
The Endothelium and Coagulopathy in SLE: Hyperhomocysteinemia as a Developing Risk Factor

R. Fijnheer, A.D. Blann .........1400
Inflammation, Insulin Resistance, and Aberrant Lipid Metabolism as Cardiovascular Risk Factors in RA

P.H. Dessein, B.I. Joffe, A.E. Stanwix .........1403
Articles
No Association of Polymorphisms in the TNF-RI and
RII Genes with Disease Severity in RA
 J.R. Glossop,
N.B. Nixon, P.T. Dawes, A.B. Hassell, D.L. Mattey .........1406
CD4+ PD-1+ T Cells Accumulate as Unique
Anergic Cells in RA SF

S. Hatachi, Y. Iwai, S. Kawano, et al .........1410
Expression of a Wide Range of Fibrocartilage Molecules at the Entheses of the Alar Ligaments Possible Antigenic Targets for RA?
 A.A. Boszczyk,
B.M. Boszczyk, R. Putz, M. Benjamin, S. Milz .........1420
Toxicity, Pharmacokinetics, and Dose-Finding
Study of Repetitive Treatment with the Humanized
Anti-IL-6 Receptor Antibody MRA in RA. Phase I/II Clinical Study
 N. Nishimoto, K. Yoshizaki, K. Maeda, et al .........1426
Increased Risk of TB in Patients with RA
 L. Carmona, C. Hernández-García, C. Vadillo, et al .........1436
Rheumatoid Forefoot Deformity: A Comparison Study of 2 Functional Methods of Reconstruction
 D. Mulcahy, T.R. Daniels, J.T-C. Lau, E. Boyle,
E. Bogoch .........1440
Diagnostic Value of Anti-Cyclic Citrullinated Peptide Antibody in Patients with RA
 X. Zeng, M. Ai, X. Tian, et al .........1451
Influence of Hormone Replacement Therapy on Disease Progression and BMD in RA

H. Forsblad D'Elia, A. Larsen, L-A. Mattsson, et al .........1456
Surgical Management of the Rheumatoid Hand: Consensus and Controversy Among Rheumatologists and Hand Surgeons
 A.K. Alderman, P.A. Ubel, H.M. Kim, D.A. Fox, K.C. Chung .........1464
Hepatitis C Virus Infection in SLE: a Case-Control Study
 G. Perlemuter, P. Cacoub, A. Sbai, et al .........1473
Patients with SLE Show Increased Platelet Activation and Endothelial Dysfunction Induced by Acute Hyperhomocysteinemia
 L-S. Tam, B. Fan, E.K. Li, et al .........1479
Polymorphism of HLA-DMA and DMB Alleles in Patients with SLE
 J. Morel, C. Da Silva Simoes,
O. Avinens, J. Sany, B. Combe, J-F. Eliaou .........1485
Onychomycosis in SLE: A Case Control Study
 A. Tlacuilo-Parra, E. Guevara-Gutierrez, J. Mayorga,
I. Garcia-De La Torre, M. Salazar-Paramo .........1491
Multiple Autoantibodies Form the Glomerular Immune Deposits in Patients with SLE
 M. Mannik, C.E. Merrill,
L.D. Stamps, M.H. Wener .........1495
Do Traditional Gail Model Risk Factors Account for Increased Breast Cancer in Women with Lupus?

S. Bernatsky, R. Ramsey-Goldman,
J-F. Boivin, et al .........1505
Tolerability of Mycophenolate Mofetil in
Patients with SLE
 M.M. Riskalla, E.C. Somers,
R.A. Fatica, W.J. McCune .........1508
Damage Accrual in Southern Chinese
Patients with SLE

C.C. Mok, C.T.K. Ho, R.W.S. Wong, C.S. Lau .........1513
Transforming Growth Factor ß1 Gene Polymorphism in Patients with SSc

Y. Sugiura, S. Banno, Y. Matsumoto, et al .........1520
Serum Concentrations of the CXC Chemokines
IL-8 and Growth-Regulated Oncogene-a Are
Elevated in Patients with SSc

S. Furuse, H. Fujii, Y. Kaburagi, et al .........1524
Elevated Vascular Endothelial Growth Factor in SSc

J-J. Choi, D-J. Min, M-L. Cho, et al .........1529
Genetic Background of Japanese Patients with Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: Association of HLA-DRB1*0901 with Microscopic Polyangiitis
 N. Tsuchiya, S. Kobayashi, A. Kawasaki, et al .........1534
Relative Importance of CCR5 and Antineutrophil Cytoplasmic Antibodies in Patients with WG

Y. Zhou, D. Huang, C. Farver, G.S. Hoffman .........1541
Influence of Age, Sex, and Place of Residence on Clinical Expression of GCA in Northwest Spain
 M.A. Gonzalez-Gay, C. Garcia-Porrua,
J.C. Amor-Dorado, J. Llorca .........1548
Pure Sensory Neuropathy in Primary SS. Longterm Prospective Followup and Review of the Literature
 J. Font, M. Ramos-Casals, G. de la Red, et al .........1552
Efficacy and Safety of Mesalazine (Salofalk®)
in an Open Study of 20 Patients with AS
 J.C. van Denderen, I.E. van der Horst-Bruinsma,
P.D. Bezemer, B.A.C. Dijkmans .........1558
Urinary Collagen Type II C-Telopeptide Fragments Are Sensitive Markers of Matrix Metalloproteinase-Dependent Cartilage Degradation in Rat Adjuvant-Induced Arthritis
 F. De Ceuninck, M. Sabatini, V. Renoux,
G. de Nanteuil, P. Pastoureau .........1561
Prolonged Treatment of Human OA Chondrocytes
with Insulin-like GF-I Stimulates Proteoglycan Synthesis But Not Proteoglycan Matrix
Accumulation in Alginate Cultures

R.F. Loeser, M.D. Todd, B.L. Seely .........1565
A Home-Based Protocol of Electrical Muscle Stimulation for Quadriceps Muscle Strength in Older Adults with OA of the Knee
 L.A. Talbot, J.M. Gaines,
S.M. Ling, E.J. Metter .........1571
The Impact of Incident Vertebral and Non-Vertebral Fragility Fractures on Health-Related Quality of Life in Established Postmenopausal Osteoporosis: Results from the Teriparatide Randomized, Placebo-Controlled Trial in Postmenopausal Women
 A.K. Oglesby,
M.E. Minshall, W. Shen, S. Xie, S.L. Silverman .........1579
Learning from Pain Scales: Patient Perspective
 P. Clark, P. Lavielle, H. Martínez .........1584
Prevalence of Rheumatic Diseases in Greece:
A Cross-Sectional Population Based Epidemiological Study. The ESORDIG Study

A. Andrianakos, P. Trontza, F. Christoyannis, et al .........1589
Pediatric Rheumatology
Measuring Health Status in Early JIA: Determinants
and Responsiveness of the Child Health Questionnaire
 A.M. Selvaag, B. Flatø, G. Lien, D. Sørskaar,
O. Vinje, Ø. Førre .........1602
Increased Expression of a(1,3)-Fucosyltransferase-VII and P-Selectin Binding of SF T Cells in JIA
 F. De Benedetti, P. Pignatti, M. Biffi, et al .........1611
Case Reports
Goodpasture-like Syndrome Induced by
D-Penicillamine in a Patient with SSc: Report and Review of the Literature
 C.T. Derk, S.A. Jimenez .........1616
Cutaneous Vasculitis A Case for Laparotomy?
 L. Willcocks, G. Chelliah, R. Brown, P. Bacon .........1621
Fulminant Hepatitis After Infliximab in a Patient with Hepatitis B Virus Treated for an Adult Onset Still's Disease

M. Michel, C. Duvoux, C. Hezode, D. Cherqui .........1624
Images in Rheumatology
Dactylitis of the Thumb Extending to the
Radial Bursa

I. Olivieri, E. Scarano, A. Padula, V. Giasi .........1626
Hand Involvement in Primary Biliary Cirrhosis
in an 85-Year-Old Woman

M. Stone, R.D. Inman, D. Salonen .........1628
OMERACT 6
International Consensus Conference on Outcome Measures in Rheumatology, Gold Coast, Australia, April 11-14, 2002
Current Status of Outcome Measure Development
for Clinical Trials in Systemic Sclerosis.
Report from OMERACT 6

P.A. Merkel, P.J. Clements, J.D. Reveille,
M.E. Suarez-Almazor, G. Valentini, D.E. Furst .........1630
Outcome Variables for OA Clinical Trials:
The OMERACT-OARSI Set of Responder Criteria
 T. Pham, D. van der Heijde, M. Lassere, et al .........1648
OMERACT 6: Conference on Outcome Measures in Rheumatology Acknowledgements.........1655
Correspondence
Patient Expectations and Total Joint Arthroplasty
G. Woolhead, J. Donovan, P. Dieppe .........1656
Reply N.M. Mahomed, M.H. Liang, L.H. Daltroy,
P.R. Fortin, J.N. Katz .........1657
Letter
Development of TB in a Patient Treated with
Infliximab Who Had Received Prophylactic
Therapy with Isoniazid
J.P. Ruiz, N.O. Centeno, E.R. Alvarez .........1657
Book Reviews
Living Well with Arthritis: A Sourcebook for Understanding and Managing Your Arthritis .........1658
Clinical Pain Management .........1659
Notices

|